Ryan Zimmerman
Stock Analyst at BTIG
(4.60)
# 313
Out of 4,622 analysts
158
Total ratings
60.98%
Success rate
17.81%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
IART Integra LifeSciences Holdings | Upgrades: Neutral | n/a | $19.23 | - | 6 | Oct 7, 2024 | |
ZBH Zimmer Biomet Holdings | Maintains: Buy | $134 → $126 | $103.50 | +21.74% | 7 | Oct 3, 2024 | |
GEHC GE HealthCare Technologies | Upgrades: Buy | $100 | $91.03 | +9.85% | 2 | Sep 18, 2024 | |
ALC Alcon | Maintains: Buy | $98 → $104 | $96.69 | +7.56% | 10 | Sep 12, 2024 | |
SOLV Solventum | Initiates: Neutral | n/a | $68.14 | - | 1 | Sep 5, 2024 | |
GKOS Glaukos | Maintains: Buy | $131 → $139 | $126.90 | +9.54% | 9 | Aug 28, 2024 | |
GMED Globus Medical | Maintains: Buy | $75 → $77 | $70.57 | +9.11% | 9 | Aug 28, 2024 | |
ISRG Intuitive Surgical | Maintains: Buy | $469 → $494 | $484.78 | +1.90% | 14 | Aug 28, 2024 | |
PEN Penumbra | Maintains: Buy | $187 → $224 | $203.19 | +10.24% | 14 | Aug 28, 2024 | |
SYK Stryker | Maintains: Buy | $360 → $374 | $355.60 | +5.17% | 13 | Aug 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $11 | $5.73 | +91.97% | 3 | Jul 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $50.20 | +45.42% | 4 | Jul 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $31.61 | +67.67% | 7 | Jul 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $56 → $55 | $41.69 | +31.93% | 7 | Jul 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $3 | $0.60 | +398.42% | 2 | May 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.26 | - | 5 | May 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.31 | - | 3 | Apr 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.19 | +236.13% | 1 | Jan 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $3.07 | +95.44% | 6 | Dec 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.41 | - | 3 | Nov 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $59 → $52 | $24.61 | +111.30% | 7 | Oct 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.58 | - | 2 | Sep 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $14.16 | +97.74% | 4 | Apr 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $140.62 | +42.23% | 1 | Apr 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $233.10 | +50.15% | 1 | Apr 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $130 | $116.12 | +11.95% | 3 | Apr 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $71.70 | - | 1 | Oct 31, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $89.36 | +43.24% | 4 | Dec 17, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $4.83 | +210.56% | 1 | Nov 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $91 | $79.81 | +14.02% | 1 | Feb 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $16.81 | +149.85% | 1 | Sep 23, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $7.84 | +569.98% | 3 | Aug 14, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $14.71 | - | 3 | Apr 2, 2020 |
Integra LifeSciences Holdings
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $19.23
Upside: -
Zimmer Biomet Holdings
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $126
Current: $103.50
Upside: +21.74%
GE HealthCare Technologies
Sep 18, 2024
Upgrades: Buy
Price Target: $100
Current: $91.03
Upside: +9.85%
Alcon
Sep 12, 2024
Maintains: Buy
Price Target: $98 → $104
Current: $96.69
Upside: +7.56%
Solventum
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $68.14
Upside: -
Glaukos
Aug 28, 2024
Maintains: Buy
Price Target: $131 → $139
Current: $126.90
Upside: +9.54%
Globus Medical
Aug 28, 2024
Maintains: Buy
Price Target: $75 → $77
Current: $70.57
Upside: +9.11%
Intuitive Surgical
Aug 28, 2024
Maintains: Buy
Price Target: $469 → $494
Current: $484.78
Upside: +1.90%
Penumbra
Aug 28, 2024
Maintains: Buy
Price Target: $187 → $224
Current: $203.19
Upside: +10.24%
Stryker
Aug 28, 2024
Maintains: Buy
Price Target: $360 → $374
Current: $355.60
Upside: +5.17%
Jul 15, 2024
Maintains: Buy
Price Target: $8 → $11
Current: $5.73
Upside: +91.97%
Jul 15, 2024
Maintains: Buy
Price Target: $72 → $73
Current: $50.20
Upside: +45.42%
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $31.61
Upside: +67.67%
Jul 15, 2024
Maintains: Buy
Price Target: $56 → $55
Current: $41.69
Upside: +31.93%
May 16, 2024
Maintains: Buy
Price Target: $2 → $3
Current: $0.60
Upside: +398.42%
May 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.26
Upside: -
Apr 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $10.31
Upside: -
Jan 23, 2024
Initiates: Buy
Price Target: $4
Current: $1.19
Upside: +236.13%
Dec 27, 2023
Maintains: Buy
Price Target: $4 → $6
Current: $3.07
Upside: +95.44%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $6.41
Upside: -
Oct 4, 2023
Maintains: Buy
Price Target: $59 → $52
Current: $24.61
Upside: +111.30%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $15.58
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $14.16
Upside: +97.74%
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $140.62
Upside: +42.23%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $233.10
Upside: +50.15%
Apr 17, 2023
Maintains: Buy
Price Target: $125 → $130
Current: $116.12
Upside: +11.95%
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $71.70
Upside: -
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $89.36
Upside: +43.24%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $4.83
Upside: +210.56%
Feb 22, 2021
Maintains: Buy
Price Target: $84 → $91
Current: $79.81
Upside: +14.02%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $16.81
Upside: +149.85%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $7.84
Upside: +569.98%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $14.71
Upside: -